Presentation is loading. Please wait.

Presentation is loading. Please wait.

Allergic Rhinitis.

Similar presentations


Presentation on theme: "Allergic Rhinitis."— Presentation transcript:

1 Allergic Rhinitis

2 References Allergic rhinitis management pocket reference 2008.
Allergy 2008: 63: 990–996. Pharmacotherapy: A pathophysiologic Approach. 7th Edition 2008. Safety of Antihistamines in Children. Drug Safety 2001; 24 (2): Second-Generation Antihistamines Actions and Efficacy in the Management of Allergic Disorders. Drugs 2005; 65 (3): 2

3 allergic rhinitis <immunology> An inflammatory response in the nasal passages to an allergic stimulus. Often includes: nasal congestion, sneezing, runny or itchy nose

4 Allergic Rhinitis The most common atopic disease
The hallmark of ~: a temporal relationship between the exposure to allergens & the development of nasal symptoms It takes at least 2 years of exposure to aeroallergens (airborne environmental allergens) to develop AR (thus, very rare in children <1 year) The prevalence of AR: lowest in children < 5 yrs highest 2nd---- 4th decades Genetic predisposition (60%)

5 In a sensitized individual, allergic rhinitis occurs when mucous membranes are exposed to inhaled allergenic materials that elicit a specific response mediated by immunoglobulin E (IgE). 5

6 Exposure to antigen stimulates IgE production and
Allergen sensitization and the allergic response. A. Exposure to antigen stimulates IgE production and sensitization of mast cells with antigen specific IgE antibodies. B. Subsequent exposure to the same antigen produces an allergic reaction when mast cell mediators are released. 6

7 Mast cells degranulating and releasing vasoactive amines.

8 Classification persistent AR is classified as seasonal or perennial
Seasonal: repetitive and predictable symptoms (severe) Perennial: symptoms persist throughout the year without any obvious seasonal pattern WHO: replace terms with intermittent or persistent

9 symptoms symptoms lntermiHent Persistent Mild Moderate-Severe
<4 days per week or <4 consecutive weeks Persistent symptoms >4 days/week and >4 consecutive weeks Mild all of the following normal sleep Moderate-Severe one or more items sleep disturbance impairment of doily activities, sport, leisure impairment of school or work troublesome symptoms no impairment of doily activities, srrt, leisure no impairment of work and schoo symptoms present but not troublesome

10 Allergic Rhinitis Most patients develop symptoms before age 30
Asthma develops in about 19% of children with rhinitis (more likely with perrenial allergic rhinitis) The term “rhinitis” refers to the inflammation of the nasal mucous membranes. Whenever a a causative allergen can be identified-7 allergic rhinitis It is difficult sometimes to distinguish between different types of rhinitis Comparison between different types of rhinitis

11 Features of Common Rhinitis Symptoms
Allergic rhinitis Infectious rhinitis Vasomotor rhinitis Rhinitis Medicamentosa Etiology Allergen Viral or bacterial Unknown Tachyphylaxis to topical decongestants Symptoms Rhinorrhea, congestion, sneezing, pruritis, cough with postnasal drip ocular itching etc Fever (more common in children), mucupurulent rhinorrhea, scratchy throat, congestion, cough Rhinorrhea, congestion Congestion Pattern Perennial or seasonal Any time Temporal relationship with use of topical decongestant Associated Factors Concurrent atopic disease, family history None Affects women primarily, strong odours, alcohol, stress, change in humidity and temperature Overuse of topical decongestants, concurrent use of antihypertensive therapy

12 Perennial Allergic Rhinitis 1
Caused by continuous exposure to many different types of allergens Dust Mite-7 the most common cause of perennial allergic rhinitis Commonly: household dust mites, molds, cockroaches, house pets Less commonly: cottonseed & flaxseed (found in fertilizers, hair setting preparations and foods); some vegetable gums (found in hair setting prep & foods)

13 Caused by: Dust mites

14 Perennial Allergic Rhinitis 2
Dust mite: thrive in carpets, beddings & reproduce best in warm (18-21ºC) humid (>50%) environment found in most homes Mites feed on human skin scales and their own faeces. Mite itself is not allergen, the main allergen is the glycoprotein that coats their faeces. Dust mite remain airborne for about 30 minutes after being disturbed Molds: grow best in warm, moist environment Cat-derived allergens: light small proteins secreted through the sebaceous glands in the skin. May remain airborne for up to 6 hrs. Can be detected at home even 6 months after removal of the cat.

15 Seasonal Allergic Rhinitis
Caused by wind-borne plant pollens (e.g. tree, grass. etc) “hay fever”, and “rose fever” are terms related to seasons associated grass pollinosis and NOT associated with FEVER!

16 - Nasal Passages AOc(gCfls , -

17 Complications Sinusitis Recurrent otitis media & hearing loss
Patients who develop: fever, purulent nasal discharge, frequent HA, earache refer to Dr. for evaluation and treatment

18 Symptoms of Allergic Rhinitis
Ocular: itching, lacrimation, mild soreness, puffiness & conjuctival erythema Nasal: congestion, watery rhinorrhea, itching, sneezing, postnasal drip and nasal pruritus Head & Neck: loss of taste and smell, mild sore throat due to postnasal drip, earache, sinus HA, itching of the palate and throat Systemic: malaise & fatigue:

19 Physical Assessment “allergic shiners” -7 venous/lymphatic congestion
Chronic mouth breathing-7 highly arched palate A horizontal crease across the lower third of the nose (in patients repeatedly rub their noses upward) called “nasal salute” Nasal mucosa: pale & swollen Nasal secretions: clear & watery Eyes: watery with scleral & conjuctival erythema and periorbital edema

20 Allergic shiners Arched palate because of mouth breathing Periorbital edema

21 Repooted performan of the allergic lute (a)
r ults 1n a n al cr aso (b). lute (a)

22 Allergic Rhinitis Questionnaire
Response Choices 1. Do you have any of the following symptoms? Symptoms on only one side of your nose Yes No Thick,green or yellow discharge from your nose (see NOTE) Postnasal drip (down the back of your throat) with thick mucus and/or runny nose (see NOTE} Facial pain (see NOTE} Recurrent nosebleeds oss of smell (see NOTE} 2. Do you have any of the follow ing symptoms for at least one hour on most days (or on most days during the season if your symptoms are seasonal)? Watery runny nose Sneezing, especially violent and in bouts Nasal obstruction Nasal itching Conjunctivitis (red,itchy eyes) 22

23 The ymptom de cribed in Que tion 1 are u ually OT found in allergic rhiniti . The pre ence of ANY ONE of them ugge t that alternative diagno e hould be inve tigated. Con ider alternative diagno­ e and/or referral to a peciali t. NOTE: Purulent di charge po tna al drip facial pain and lo of n1ell are common ymptom of inu iti al o inu iti . Becau e mo t patient with have rhiniti (though not alway allergic in origin) in thi ituation the clinician po hould al o evaluate the i bili ty of allergic rhini ti . The pre ence of watery runny no e with ONE OR MORE of the other ympto1n li ted in Que tion 2 ugge t patient n1ent. allergic rhiniti and indicate that the hould undergo further diagno tic a e - The pre ence of watery runny no e ALONE ugge t that the patient MAY have allergic rhiniti . (Addi ­ tionally on1e patient with allergic rhiniti have only na al ob truction a a cardinal ymptom.)

24 Medication Class Symptoms Controlled Comments
TABLE Pharmacotherapeutic Options For Allergic Rhinitis Medication Class Symptoms Controlled Comments Antihistamines Systemic Sneezing, rhinorrhea, itching, For seasonal allergic rhinitis, begin treatment before allergen exposure. Nonsedating agents should be tried first. If ineffective or too expensive for the patient,the older agents may be used. For perennial allergic rhinitis, use an intranasal steroid as an alternative to or in combination with systemic antihistamines. Logical addition to nasal steroids if ocular symptoms are present. Option for seasonal allergic rhinitis.Warn patients of potential drowsiness. conj unctivitis Ophthalmic Intranasal Decongestants Systemic Topical I ntranasal corticosteroids Conjunctivitis Sneezing, rhinorrhea,nasalpruritus Nasal congestion Nasal congestion Only needed w hen nasal congestion is present. Only needed w hen nasal congestion is present. Do not exceed 3-5 days. For seasonal allergic rhinitis, an option w hen congestion is present. Must begin therapy before allergen exposure. Excellent choice for perennial rhinitis. Prevents symptoms; therefore,for seasonal allergic rhinitis,use before offending allergen's season starts. For perennial rhinitis, improvement may not be seen for up to 1 month. Sneezing, rhinorrhea, itching, nasal congestion Mast cell stabilizers See comments Intranasal ant icholinergics Rhinorrhea Reserve for use w hen above therapies fa il or cannot be tolerated.

25 Oral H, antihistamines H,-blockers 2nd generation blockage of H1
Name and Also known as Generic name Mechanism of ac­ tion Side effects Comments Oral H, antihistamines H,-blockers 2nd generation blockage of H1 receptor -some anti-allergic activity new generation drugs can be used once daily no development of tachyphylaxis 2nd generation no sedation for most drugs -no anti-cholinergic effect no cardiotoxicity acrivasti ne has sedative effects oral azelasti ne may induce sedation and a bitter taste Firsine therapy except in Moderate/ Severe Persistent Allerg ic Rhinitis -2nd generation oral HI­ blockers are preferred for their favorable efficacy/ safety ratio and pharma­ cokinetics;first generation molecules are no longer recommended because of their unfavorable safety/ efficacy ratio Rapidly effective (less than 1hr) on nasal and ocular symptoms • Moderately effective on nasal congestion * Cardiotoxic drugs (astemizole,terfenadine) are no longer marketed in most countries Cetirizine Ebastine Fexofenadine Loratadine Mizolastine Acr ivasti ne Azelastine Mequitazine New products Desloratadine Levocetirizine Rupatadine

26 half-life; tmax = time after oral dose
Table Ill. Pharmacokinetic and pharmacodynamic properties of second-generation antihistamines tmax (h) Cetirizine Fexofenadine Desloratadine Loratadine ] ,137] ] ] Onset of action (h) ] , ] ] ] F (%) ,135] 921154] 871155] ::: ] F, food effects Delayl1561 Decreased 25%11571 No effect1158l Increased 43%11591 Vd (Ukg) ,160,161] ] NA ,161] Protein binding (%) ] ,163] ] First-pass metabolism Limited1162l Moderate1155l Extensive1162l Hepatic metabolism Negligiblel1641 CYP3A411651 CYP3A4 CYP2D61166·1671 Active metabolites None11621 Hydroxylated 11551 Descarboethoxy (desloratadine )11621 Elimination renal (%) 70 12 44 :::.20 unchanged fecal (%) 101135) 801154] 44 (as metabolites)I155J 40 (as metabolites)l1641 t•h (h) ] ,137] ,142,143,168,169] ,143] Duration of action (h) 24188,149,160, ] 241146,147,149] 241151] <241173,174] CYP = cytochrome P450; F = fraction absorbed orally ; NA = not available; t•h = elimination half-life; tmax = time after oral dose administration until maximal plasma concentration ; Vd = volume of distribution.

27 Table VIII. Adverse effects (% of patients) with second-generation antihistamines
Cetirizine (n = 2034)l3601 Desloratadine (n = 1655)l155l Fexofenad ine (n = 679)l3581 Loratadine (n = 1926)[3591 Drowsiness/somnolence 13.7 2.1 1.3 8 Insomnia < 1 <2 Headache >2 10.6 12 Fatigue 5.9 4 Dry mouth 5.0 3.0 3 Pharyngitis 2.0 4.1 3.2 Dizziness <2.2 Gastrointestinal distress Dysmenor rhoea 1.5

28 NS = not stated in product labelling.
Table XV. Recommended dailya oral dosage of second-generation antihistamines Drug Adults Children Elderly Renal impairment Hepatic impairment Cetirizine 5-1Omg 6-11 years: 5-1Omg 0.5-5 years: 2.5- Smg 5mg Desloratadine >12 years: 5mg 5mg every 48 hours Fexofenadine 180mg 6-11 years: 30mg twice daily 60mg Loratadine 10mg >6 years: 1Omg 2-5 years: 5mg NS 1Omg every 48 hours a Unless specified. NS = not stated in product labelling.

29 Azelastine Levocabastine Olopatadine
- blockage of H1 receptor -some anti-ollergic activity for azelastine -Minor local side effects - Azelastine : bitter taste in some patients Rapidly effective (less than 30 min) on nasal or ocular symptoms local H, antihistamines (in­ tranasal, intraocular) Intranasal glucocortico­ steroids Beclomethasone dipropionate Budesonide Ciclesonide Flunisolide Fluticasone propionate Fluticasone furoate Mometasone furoate Triamcinolone acetonide -potently reduce nasal inflammation - reduce nasal hyperreactivity -Minor local side effects -Wide margin for systemic side effects - Growth concerns with BDP only -In young children consider the combination of intranasal and inhaled drugs The most effective pharmacologic treatment of allergic rhinitis;first-line treatment for Moder­ ate/ Severe Persistent Allergic Rhinitis Effective on nasal congestion Effective on smell Effect observed after hrs but maximal effect after a few days Patients should be advised on the proper method of administering intranasal glucocortico­ steroids, including the importance of directing the spray laterally rather than medially (toward the septum) in the nose

30 30 Oral I IM glucocortico- steroids
Dexamethasone Hydrocortisone Methylpredisolone Prednisolone Prednisone Triamcinolone Betamethasone Deflazacort - Potently reduce nasal inflammation -Reduce nasal hyperreactivity - Sffstemic side e ects common in particular for IM drugs -Depot injections may cause local tissue atrophy When possible, intranasal glucocortico- steroids should replace oral or IM drugs However, a short course of oral gluco- corticosteroids may be needed if moderate/ severe symptoms Local cromones (intranasal, intraocular) Cromoglycate Nedocromil Naaga -mechanism of action poorly known -Minor local side effects Intraocular cromones are very effective Intranasal cromones are less effective and their effect is short lasting Overall excellent safety Oral decongestants E hedrine P enylephrine Phenyl- propanolamine Pseudoephedrine Oral Hl- antihistam ine- decongestant combinat ion - drmpathomimetic rug -relieve symptoms of nasal congestion Hypertension Palpitations Restlessness -Agitation -Tremor -Insomnia -Headache Dry mucous membranes -Ur inary retention Exacerbation of aucoma or yrotoxicos is Use oral decongestants with caution in patients with heart disease Oral Hl- antihistamine decongestant combination products may be more effective than either product alone but side effects are combined 30


Download ppt "Allergic Rhinitis."

Similar presentations


Ads by Google